Biotest - News

Ad-hoc News

06/21/2011	Ad-hoc: Biotest AG: Agreement with Abbott
04/28/2011	Ad-hoc: Biotest AG: Ad hoc ANNOUNCEMENT
03/22/2011	Ad-hoc: Biotest AG: Ad-hoc RELEASE Announcement according to § 15 Sec. 1 Securities Trading Act (WpHG)
02/15/2011	Ad-hoc: Biotest AG: Increase in sales of more than 5%
07/14/2010	Ad-hoc: Biotest AG: Preliminary Results
02/16/2010	Ad-hoc: Biotest AG: Biotest significantly increases sales, EBIT above the high level of last year
10/23/2009	Ad-hoc: Biotest AG: Biotest agrees to sell its Medical Diagnostics business to Bio-Rad
08/12/2009	Ad-hoc: Biotest AG: Ad-hoc RELEASE; Announcement according to § 15 Sec. 1 Securities Trading Act (WpHG)
05/07/2009	Ad-hoc: Biotest AG: Press Release- Biotest AG: 'Biotest sales and EBIT growth in first quarter; extension of credit facility'
02/04/2009	Ad-hoc: Biotest AG: Biotest records significant growth in sales and earnings, Majority shareholder terminates discussion about shares' sale
10/28/2008	Ad-hoc: Biotest AG: Majority shareholder of Biotest AG in discussions about selling shares
07/18/2008	Ad-hoc: Biotest AG: strong first half year, profit target raised
05/27/2008	Ad-hoc: Biotest AG: Forecast for turnover and profit raised
02/22/2008	Ad-hoc: Biotest AG: Biotest marked increase in sales and earnings recorded in 2007
09/21/2007	Ad-hoc: Biotest AG:Biotest successfully concludes 10% capital increase
09/11/2007	Ad-hoc: Biotest AG:Biotest AG acquires plasma protein unit from Nabi Biopharmaceuticals Corp.
07/19/2007	Ad-hoc: Biotest AG: Biotest significantly increases sales and earnings target for 2007
02/14/2007	Ad-hoc: Biotest AG: Increase in sales and earnings in financial year 2006 higher than expected
05/03/2006	Ad-hoc: Biotest AG:Biotest and Sanquin plan a strategic alliance in plasma products
10/10/2005	Ad hoc news: Biotest fixes subscription price
09/06/2005	Ad hoc news: Biotest AG increases capital stock by up to EUR 3.9 million
06/30/2005	Ad hoc news: Biotest AG increases capital stock by 2.92 million Euro
03/24/2005	Ad hoc news: Change of the Supervisory Board
03/16/2005	Ad hoc news: Excellent preliminary result: Biotest achieves group profit of EUR 5.0 million in 2004
04/25/2003	Ad hoc news: Biotest: Positive operating profit before special items from core activities
03/11/2003	Ad hoc news: Notice according to §15 WPHG (German Security Trading Act) Biotest AG's year-end result for 2002 depressed by restructuring expenditure despite sales increase

Corporate News

12/12/2011	News: Biotest AG: Clinical development of BT-062 in multiple myeloma expands into combination therapy
11/24/2011	News: Biotest AG: Tregalizumab (BT-061) shows efficacy in Chronic Plaque Psoriasis
11/10/2011	News: Biotest AG: Biotest: Significant Increase in Profit after Tax
08/11/2011	News: Biotest AG: First time Revenue and EBIT contribution by Biotherapeutics Segment; continuing difficult Plasma Protein Product Environment
08/01/2011	News: Biotest AG: Sale of Microbiological Monitoring business to Merck KGaA completed
06/22/2011	News: Biotest AG: Pentaglobin(R) shows high binding capacity against the current EHEC strain and its Shiga-like toxin 2
06/21/2011	News: Biotest AG: Abbott and Biotest Announce Global Agreement to Development and Commercialize Novel Antibody for Autoimmune Diseases
05/12/2011	News: Biotest AG: Biotest AG: Annual General Meeting approves dividend increase
05/10/2011	News: Biotest AG: Sales increase in the first quarter
03/22/2011	News: Biotest AG: Biotest: Monoclonal antibody BT-061 in combination with methotrexate demonstrates good efficacy in Rheumatoid Arthritis
03/22/2011	News: Biotest AG: Sales increase despite difficult market environment
01/27/2011	News: Biotest AG: Interim analysis of the Cytotect(R) Phase III trial in congenital cytomegalovirus (CMV) infection shows clear indication of efficacy
01/19/2011	News: Biotest AG: Biotest erwirbt Vertriebsgesellschaft in Brasilien
12/06/2010	News: Biotest AG: Clinical and pre-clinical data emphasise the potential of
11/17/2010	News: Biotest AG: Biotest: Pre-clinical studies demonstrate high efficacy of BT-062 in solid tumours
11/08/2010	News: Biotest AG: Biotest experiences sales growth
11/03/2010	News: Biotest AG: Biotest submits BivigamTM dossier for regulatory approval to US Food and Drug Administration
10/21/2010	News: Biotest AG: Monoclonal antibody BT-061 shows potential in the indication multiple sclerosis
08/12/2010	News: Biotest AG: Positive perspective despite difficult environment
08/11/2010	News: Biotest AG: Development of BT-062 makes further progress with start of a new clinical trial
08/10/2010	News: Biotest AG: Immunomodulatory antibody BT-061 shows competitive efficacy in the indication Rheumatoid Arthritis
08/10/2010	News: Biotest AG: BT-061 patent protection significantly expanded
07/14/2010	News: Biotest AG: Biotest increases sales despite greater financial pressure
05/11/2010	News: Biotest AG: Biotest shows sales growth in first quarter 2010 despite a difficult environment
05/06/2010	News: Biotest AG: Annual General Meeting 2010: Shareholders Approve Dividend of EUR 0.34 per Ordinary Share and EUR 0.40 per Preference Share
05/06/2010	News: Biotest AG: Biotest has recorded sales growth in first quarter 2010 despite a difficult environment
03/19/2010	News: Biotest AG: 2009 brings additional growth
03/17/2010	News: Biotest AG: Monoclonal antibody BT-061 shows efficacy in the indication psoriasis
01/06/2010	News: Biotest AG: Sale of Medical Diagnostics business to Bio-Rad completed
12/07/2009	News: Biotest AG: Immunoconjugate BT-062 shows first data of clinical efficacy
12/03/2009	News: Biotest AG: European Commission grants approval of Zutectra(R)
11/05/2009	News: Biotest AG: Biotest increases sales and earnings
10/23/2009	News: Biotest agrees to sell its Medical Diagnostics business to Bio-Rad Biotest AG:
10/20/2009	News: Biotest AG: Monoclonal antibody BT-061 shows efficacy in patients with rheumatoid arthritis
09/30/2009	News: Biotest AG: Clinical development of BT-063 started
09/28/2009	News: Biotest AG: Biotest AG receives positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for approval of Zutectra across the EU
08/12/2009	News: Biotest AG:Biotest remains successful
07/07/2009	News: Biotest AG: Further interim analyses confirm good clinical efficacy of the BT-061 monoclonal antibody.
05/15/2009	News: Biotest AG: Successful Start into 2009
05/07/2009	News: Biotest AG: Annual General Meeting: Shareholders Approve Dividend of EUR 0,30 per Ordinary Share and EUR 0,36 per Preference Share
04/07/2009	News: Biotest AG: Expansion of product offering and capacity
03/11/2009	News: Biotest AG: Successful Financial Year 2008
02/11/2009	News: Biotest AG: Biotest acquires further plasmapheresis centre
01/21/2009	News: Biotest AG: Cooperation secures additional plasma protein capacity
01/12/2009	News: Biotest AG: Expansion of plasma protein product range
12/15/2008	News: Biotest AG: Enhanced property rights for BT-062
12/10/2008	News: Biotest AG: Biotest expands plasma recovery capacities
12/10/2008	News: Biotest AG: European approval for Haemonine®
10/17/2008	News: Biotest AG: Biotest: proceeding successfully
09/22/2008	News: Biotest AG: Biotest: Promising start of clinical trial with BT062
09/08/2008	News: Biotest AG: Biotest: monoclonal antibody BT-061 shows clear indications of efficacy in the treatment of Psoriasis
08/18/2008	News: Biotest AG: Biotest: US approval increases potential of diagnostic business
08/07/2008	News: Biotest AG: Biotest strengthens self-sufficiency in Plasma Proteins
07/29/2008	News: Biotest AG: Biotest awarded patent protection in the USA
05/27/2008	News: Biotest AG: Payout of dividends increased, forecast improved
05/16/2008	News: Biotest AG: Successful start into the Year 2008
05/05/2008	News: Biotest AG: research into additional indications for monoclonal antibody BT-061
04/14/2008	News: Biotest AG: European approvals expand the market potential for plasma proteins
04/07/2008	News: Biotest AG: Biotest: Successful launch of plasma protein business in the USA
03/11/2008	News: Biotest AG: Biotest achieves major milestones in the development of biotherapeutics
02/22/2008	News: Biotest AG: 2007 a very successful year for Biotest
12/05/2007	News: Biotest AG:Biotest successfully completes acquisition of Nabi Biologics assets
11/09/2007	News: Biotest AG: Nabi shareholders approve sale of Biologics Business Unit to Biotest
11/05/2007	News: Biotest AG: Biotest: plasmapheresis centre in Dortmund opens
09/11/2007	News: Biotest AG:Biotest AG acquires plasma protein business unit from Nabi Biopharmaceuticals Corp.
08/10/2007	News: Biotest AG: Biotest remains on course for growth
08/01/2007	News: Biotest AG:Biotest and Abbott cooperate on a clinical trial for the expansion of the indication of Cytotect®
07/16/2007	News: Biotest AG: New clinical results increase market potential of Cytotect®
06/25/2007	News: Biotest AG: Biotest achieves further milestones in its monoclonal antibody development
06/15/2007	News: Biotest receives go-ahead to export culture media to the USA
05/03/2007	News: Biotest AG: successful start to 2007
03/13/2007	News: Biotest AG: Board of Management and Supervisory Board propose 82% dividend increase
02/14/2007	News: Biotest AG: 2006 financial year considerably better than expected
01/04/2007	News: Biotest AG: Orphan drug status for Cytotect® in the USA
12/21/2006	News: Biotest AG: Major milestones achieved in the development of monoclonal antibodies. – Commencement of clinical development of BT-061.
11/14/2006	News: Biotest AG: Biotest confirms sales and earnings target following good third quarter
11/02/2006	News: Biotest AG:Biotest obtained approval for improved Hepatect® product in six European countries
10/20/2006	News: Biotest AG: New Automated Assays for TANGO® Automated Blood Bank Systems under Food and Drug Administration Review
10/20/2006	News: Biotest AG: Biotest Diagnostics Corporation Announces Appointment of Vice President, Transfusion Diagnostics
10/20/2006	News: Biotest AG: Biotest announces important Milestone for Full Line of Manual Blood Bank Reagents
10/20/2006	News: Biotest AG: Olympus and Biotest redefine distribution relationship for Tango® systems
09/28/2006	News: Biotest AG: EMEA Committee in favour of Orphan Drug status for Cytotect®
08/14/2006	News: Biotest AG: Continuing growth
07/11/2006	News: Biotest secures exclusive rights to ImmunoGen’s world leading cytotoxic agent technologyest AG:
05/11/2006	News: Biotest AG: Stock option programme fails to achieve required majority
05/11/2006	News: Biotest AG:Good start to 2006 – a year of growth: Group sales up by 21%, overproportional growth recorded in earnings
03/22/2006	News: Biotest AG:“Focused research, global growth”: Biotest increases its market share worldwide and announces ambitious targets for 2006
03/22/2006	News: Biotest AG:Supervisory Board announces early extension of Dr. Michael Ramroth’s (CFO), contract by five years
02/17/2006	News: Biotest AG: Successful financial year 2005: Biotest increases sales, doubles the result and reduces financial liabilities
11/14/2005	Press release: Biotest continues excellent business growth in third quarter: Revenue +9%, EBIT +43%
10/31/2005	Press release: Successful capital increase for Biotest
10/18/2005	Press release: Biotest: World’s Largest Trade Conference is Kickoff for TANGO Marketing in the U.S.
10/13/2005	Press release: Biotest: Intratect^® approved for nine European countries
10/11/2005	Press release: Biotest AG: Capital increase - Up to EUR 30 million for research and internationalisation
09/29/2005	Press release: Biotest: New study doubles the market potential of Cytotect^®
08/05/2005	Press release: Biotest enjoys continued successful business growth - EBIT +27% in first six months 2005
07/28/2005	Press release: Biotest receives approval for TANGO reagents in US
07/01/2005	Press release: Capital increase: 10 million euro in new funds for antibody research
06/29/2005	Press release: Biotest wins TANGO tender
06/28/2005	Press release: Biotest AG and Boehringer Ingelheim Enter Into
05/20/2005	Press release: Biotest AG: Dr. Thorlef Spickschen new Chairman of the Supervisory Board
05/10/2005	Press release: Biotest : Q1 2005 continues positive trend
04/19/2005	Press release: Biotest : Successful fiscal year 2004 and first quarter of 2005
02/17/2005	Press release: Biotest AG and Lonza Enter into Manufacturing Agreement
01/26/2005	Press release: Biotest recorded revenues of EUR 218 million in 2004
01/21/2005	Press release: Biotest AG and AERES Biomedical Successfully Complete Engineering of the Antibody BT-062
11/22/2004	Press release: Biotest increases operating result by 70%
09/30/2004	Press release: STRATEC and BIOTEST conclude agreement on further development of TANGO
09/29/2004	Press release: Biotest launches new antibody product
07/08/2004	Press release: 2004 General Shareholders' Meeting – Biotest shareholders approve extensive capital measures
04/02/2004	Press release: Biotest generates operating profit in 2003
03/10/2004	Press release: Biotest sells its shareholding in SIFIN
02/23/2004	Press release: Biotest and Iranian Darou Pakhsh form joint venture
02/03/2004	Press release: Management changes at Biotest
01/26/2004	Press release: Biotest generates € 222 million turnover in 2003
10/01/2003	Press release: New chairman for the Biotest supervisory board
07/10/2003	Press release: Prof. Schulz appointed as Biotest`s new Chairman
07/01/2003	Press release: Biotest's new preparation against viral infections approved
06/16/2003	Press release: Successful Treatment of SARS Patients with Biotest Drug
06/10/2003	Press release: Biotest sells its shareholding in Envitec
03/05/2003	Press release: Biotest AG continues to market medical products
02/19/2003	Press release: New French transfusion guidelines will drive growth for Biotest's blood grouping analyser
01/29/2003	Press release: Biotest approved for Prime Standard segment
07/09/2002	Press release: Cooperation of Biotest and Olympus in the US and Canadian Market
05/22/2002	Press release: Biotest considers repurchase of shares
04/15/2002	Press release: Biotest AG achieved a 5.6 % growth in sales in 2001 and maintains dividend continuity
02/19/2002	Press release: Biotest announces stock option program
02/12/2002	Press release: Biotest Executive Dr. Reiner retired
01/21/2002	Press release: Biotest fulfills sales target